Arena Pharmaceuticals Inc Net Income per Employee (ARNA), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Arena Pharmaceuticals Inc   (NASDAQ: ARNA)
 

Arena Pharmaceuticals Inc Net Income per Employee

ARNA's Quarterly Results, Trends, Rankings, Statistics
Arena Pharmaceuticals Inc recorded a cumulative net loss of $-616 million during 12 month ending in the fourth quarter 2021.
The Healthcare sector has seen employees of 519 other companies achieving higher income per employee. While Arena Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 4430 to 5142.


What is Income per Employee Ratio?






ARNA Net Income per Employee (Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -3,828,776 -3,621,025 -3,006,901 -2,626,981 -2,513,876
ARNA's Total Ranking # 5142 # 4430 # 4519 # 4421 # 4693
Seq. Net Income Change - - - - -


ARNA Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 520
Healthcare Sector # 1044
Overall Market # 5142

Net Income per Employee Statistics
High Average Low
$ 3,867,689 $ -348,749 $ -3,828,776
(Mar 31 2019)   (Dec 31 2021)







Companies with similar Income per Employee for 12 month ending Dec 31 2021, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2021Number of Employees Dec 31 2021


Date modified: 2026-09-08T15:10:29+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.